vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and TOOTSIE ROLL INDUSTRIES INC (TR). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $196.3M, roughly 1.4× TOOTSIE ROLL INDUSTRIES INC). TOOTSIE ROLL INDUSTRIES INC runs the higher net margin — 14.7% vs 0.7%, a 13.9% gap on every dollar of revenue. On growth, TOOTSIE ROLL INDUSTRIES INC posted the faster year-over-year revenue change (1.5% vs -16.5%). TOOTSIE ROLL INDUSTRIES INC produced more free cash flow last quarter ($61.0M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.

HCM vs TR — Head-to-Head

Bigger by revenue
HCM
HCM
1.4× larger
HCM
$270.8M
$196.3M
TR
Growing faster (revenue YoY)
TR
TR
+18.0% gap
TR
1.5%
-16.5%
HCM
Higher net margin
TR
TR
13.9% more per $
TR
14.7%
0.7%
HCM
More free cash flow
TR
TR
$57.6M more FCF
TR
$61.0M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
TR
TR
Revenue
$270.8M
$196.3M
Net Profit
$2.0M
$28.8M
Gross Margin
37.7%
35.7%
Operating Margin
-13.2%
17.0%
Net Margin
0.7%
14.7%
Revenue YoY
-16.5%
1.5%
Net Profit YoY
-83.6%
27.9%
EPS (diluted)
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
TR
TR
Q4 25
$270.8M
$196.3M
Q3 25
$232.7M
Q2 25
$277.7M
$155.1M
Q1 25
$324.5M
$148.5M
Q4 24
$193.4M
Q3 24
$225.9M
Q2 24
$305.7M
$150.7M
Q1 24
$153.2M
Net Profit
HCM
HCM
TR
TR
Q4 25
$2.0M
$28.8M
Q3 25
$35.7M
Q2 25
$455.0M
$17.5M
Q1 25
$11.9M
$18.1M
Q4 24
$22.5M
Q3 24
$32.8M
Q2 24
$25.8M
$15.6M
Q1 24
$15.8M
Gross Margin
HCM
HCM
TR
TR
Q4 25
37.7%
35.7%
Q3 25
34.1%
Q2 25
0.1%
36.4%
Q1 25
48.0%
35.3%
Q4 24
39.1%
Q3 24
34.1%
Q2 24
41.1%
33.5%
Q1 24
32.7%
Operating Margin
HCM
HCM
TR
TR
Q4 25
-13.2%
17.0%
Q3 25
13.9%
Q2 25
-1.3%
7.8%
Q1 25
-5.0%
15.5%
Q4 24
20.0%
Q3 24
15.6%
Q2 24
-9.0%
10.2%
Q1 24
7.3%
Net Margin
HCM
HCM
TR
TR
Q4 25
0.7%
14.7%
Q3 25
15.3%
Q2 25
163.8%
11.3%
Q1 25
3.7%
12.2%
Q4 24
11.6%
Q3 24
14.5%
Q2 24
8.4%
10.4%
Q1 24
10.3%
EPS (diluted)
HCM
HCM
TR
TR
Q4 25
$0.00
Q3 25
Q2 25
$0.52
Q1 25
$0.01
Q4 24
Q3 24
Q2 24
$0.03
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
TR
TR
Cash + ST InvestmentsLiquidity on hand
$1.4B
$176.6M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$941.0M
Total Assets
$1.8B
$1.3B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
TR
TR
Q4 25
$1.4B
$176.6M
Q3 25
$119.8M
Q2 25
$1.4B
$170.5M
Q1 25
$836.1M
$176.6M
Q4 24
$194.6M
Q3 24
$163.2M
Q2 24
$802.5M
$131.2M
Q1 24
$159.4M
Total Debt
HCM
HCM
TR
TR
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
TR
TR
Q4 25
$1.2B
$941.0M
Q3 25
$918.9M
Q2 25
$1.2B
$893.1M
Q1 25
$759.9M
$879.4M
Q4 24
$870.7M
Q3 24
$870.2M
Q2 24
$740.1M
$841.4M
Q1 24
$834.4M
Total Assets
HCM
HCM
TR
TR
Q4 25
$1.8B
$1.3B
Q3 25
$1.2B
Q2 25
$1.8B
$1.2B
Q1 25
$1.3B
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.3B
$1.1B
Q1 24
$1.1B
Debt / Equity
HCM
HCM
TR
TR
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
TR
TR
Operating Cash FlowLast quarter
$8.2M
$73.3M
Free Cash FlowOCF − Capex
$3.4M
$61.0M
FCF MarginFCF / Revenue
1.2%
31.1%
Capex IntensityCapex / Revenue
1.8%
6.3%
Cash ConversionOCF / Net Profit
4.21×
2.55×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$96.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
TR
TR
Q4 25
$8.2M
$73.3M
Q3 25
$62.2M
Q2 25
$-72.9M
$-8.5M
Q1 25
$40.3M
$3.6M
Q4 24
$68.8M
Q3 24
$61.3M
Q2 24
$-39.8M
$-12.6M
Q1 24
$21.4M
Free Cash Flow
HCM
HCM
TR
TR
Q4 25
$3.4M
$61.0M
Q3 25
$50.7M
Q2 25
$-82.2M
$-16.0M
Q1 25
$32.5M
$750.0K
Q4 24
$64.7M
Q3 24
$55.8M
Q2 24
$-49.9M
$-16.6M
Q1 24
$16.9M
FCF Margin
HCM
HCM
TR
TR
Q4 25
1.2%
31.1%
Q3 25
21.8%
Q2 25
-29.6%
-10.3%
Q1 25
10.0%
0.5%
Q4 24
33.5%
Q3 24
24.7%
Q2 24
-16.3%
-11.0%
Q1 24
11.0%
Capex Intensity
HCM
HCM
TR
TR
Q4 25
1.8%
6.3%
Q3 25
5.0%
Q2 25
3.3%
4.8%
Q1 25
2.4%
1.9%
Q4 24
2.1%
Q3 24
2.4%
Q2 24
3.3%
2.6%
Q1 24
2.9%
Cash Conversion
HCM
HCM
TR
TR
Q4 25
4.21×
2.55×
Q3 25
1.74×
Q2 25
-0.16×
-0.49×
Q1 25
3.38×
0.20×
Q4 24
3.06×
Q3 24
1.87×
Q2 24
-1.54×
-0.81×
Q1 24
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

TR
TR

Products$194.3M99%
Rental And Royalty$1.9M1%

Related Comparisons